PUBLISHER: IMARC | PRODUCT CODE: 1468256
PUBLISHER: IMARC | PRODUCT CODE: 1468256
The global ECG telemetry devices market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.22% during 2024-2032.
Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.
ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors, and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global ECG telemetry devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application, and end user.
Event Monitoring and MCT (Mobile Cardiac Telemetry)
Others
Arrhythmias
Myocardial Ischemia and Infarction
Pacemaker Monitoring
Others
Hospitals
Home Healthcare
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation).